Who invested in USIL Therapeutics?
USIL Therapeutics's investors include European Commission.

Luxembourg · Funded startup
Funding summaryUpdated 26 Oct 2026
$6.1Mraised across 1 round since 2026, from 1 source
USIL Therapeutics's investors include European Commission.
USIL Therapeutics has raised $6.1M across 1 round since 2026.
USIL Therapeutics's most recent round was a Grant of $6.1M in May 2026.
Its most recent round, $6.1M in May 2026, is also its largest on record.
USIL Therapeutics's first round on record, in May 2026, was backed by European Commission.
USIL Therapeutics's latest named round is a Grant, in May 2026.
USIL Therapeutics is based in Luxembourg.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.